Avenue Therapeutics, Inc. (ATXI)
0.2673
+0.02
(+8.66%)
USD |
OTCM |
Mar 04, 16:00
Avenue Therapeutics Cash from Investing (Quarterly) : 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Fortress Biotech, Inc. | 2.87M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Alnylam Pharmaceuticals, Inc. | -37.17M |
| Savara, Inc. | 21.47M |
| BioMarin Pharmaceutical, Inc. | -42.45M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.383M |
| Free Cash Flow | -1.743M |
| Free Cash Flow Per Share (Quarterly) | 0.1203 |
| Free Cash Flow to Equity (Quarterly) | 0.383M |
| Free Cash Flow to Firm (Quarterly) | 0.383M |
| Free Cash Flow Yield | -227.9% |